Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.

BACKGROUND N-Acetylcysteine has been shown to protect against contrast nephropathy, although the mechanisms underlying such an effect are unclear. Surprisingly, studies have shown that post-radiocontrast renal function actually improves in chronic renal failure patients receiving N-acetylcysteine. However, there have been no studies investigating the cause of this improvement. METHODS In a double-blind, placebo-controlled study, 24 patients (aged 65+/-2 years) suffering from stable mild-to-moderate renal insufficiency and undergoing elective coronary angiography were randomized to receive either placebo or N-acetylcysteine. All received similar hydration. Renal function parameters were assessed 48 h before and 48 h after radiocontrast administration. Urinary 15-isoprostane F2(t), a specific marker of oxidative stress, was measured immediately before and after the procedure. Expression of urinary alpha-glutathione S-transferase protein, a specific proximal tubular injury marker, was assessed after the procedure. RESULTS Comparing creatinine clearance values before and after angiography, a significant increase was seen in N-acetylcysteine patients (44.7+/-4.2 vs 57.2+/-6.3 ml/min/1.73 m(2); P = 0.02), whereas placebo patients presented no change (46.6+/-5.0 vs 46.9+/-4.3 ml/min/1.73 m(2); P = 0.90). After radiocontrast, urinary 15-isoprostane F2(t) levels in placebo patients increased significantly over baseline values (2.9+/-0.7 vs 10.3+/-2.1 ng/mg creatinine; P = 0.007), whereas urinary 15-isoprostane F2(t) levels in N-acetylcysteine patients remained basically unchanged (3.5+/-0.5 vs 4.1+/-0.9 ng/mg creatinine; P = 0.63). Furthermore, N-acetylcysteine treatment led to lower levels of alpha-glutathione S-transferase than did placebo treatment (0.8+/-0.2 vs 2.4+/-0.7 micro g/g; P = 0.046). CONCLUSIONS In chronic renal failure patients, the improvement in renal function induced by post-radiocontrast administration of N-acetylcysteine is strongly associated with suppression of oxidant stress-mediated proximal tubular injury.

[1]  F. Markowetz,et al.  Acetylcysteine for prevention of contrast nephropathy: meta-analysis , 2003, The Lancet.

[2]  D. Balderramo.  Acetylcysteine and renal function following coronary angiographic procedures. , 2003, JAMA.

[3]  M. Geffard,et al.  Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone. , 2003, Molecular pharmacology.

[4]  Chi‐Hang Lee,et al.  Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. , 2003, JAMA.

[5]  I. Hizoh,et al.  Radiocontrast-Induced Renal Tubular Cell Apoptosis: Hypertonic Versus Oxidative Stress , 2002, Investigative radiology.

[6]  O. Sommerburg,et al.  Oxidative stress in chronic renal failure as a cardiovascular risk factor. , 2002, Clinical nephrology.

[7]  Douglas Losordo,et al.  Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). , 2002, The American journal of cardiology.

[8]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[9]  J. Blumberg,et al.  Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. , 2001, Kidney international.

[10]  R. Safirstein,et al.  Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug. , 2000, The New England journal of medicine.

[11]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[12]  J. Wetzels,et al.  Urinary Excretion of Glutathione S Transferases Alpha and Pi in Patients with Proteinuria: Reflection of the Site of Tubular Injury , 2000, Nephron.

[13]  J. Morrow.  THE ISOPROSTANES: THEIR QUANTIFICATION AS AN INDEX OF OXIDANT STRESS STATUS IN VIVO† , 2000, Drug metabolism reviews.

[14]  A. Seguro,et al.  Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. , 1998, Kidney international.

[15]  W. H. Betts,et al.  N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. , 1995, Circulation.

[16]  C. Winterbourn,et al.  [7] Reaction of superoxide with glutathioneand other thiols , 1995 .

[17]  C. Winterbourn,et al.  Reaction of superoxide with glutathione and other thiols. , 1995, Methods in enzymology.

[18]  M. Brezis,et al.  Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. , 1991, The Journal of clinical investigation.

[19]  T. Hostetter,et al.  Oxygen consumption and oxidant stress in surviving nephrons. , 1990, The American journal of physiology.

[20]  G. Bakris,et al.  Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. , 1990, The American journal of physiology.

[21]  P. Parfrey,et al.  Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.